Want to see BIO.B full AI Analyst Report?
Bio-Rad Laboratories, Inc. Class B (BIO.B) Ratios
Bio-Rad Laboratories, Inc. Class B Ratios
BIO.B's free cash flow for Q2 2026 was $66.70M. For the 2026 fiscal year, BIO.B's free cash flow was decreased by $-32.00M and operating cash flow was $98.70M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.62 | 6.48 | 5.83 | 5.55 | 2.92 |
| Quick Ratio | 4.19 | 4.85 | 4.34 | 4.29 | 2.08 |
| Cash Ratio | 1.03 | 1.04 | 0.77 | 0.76 | 0.69 |
| Solvency Ratio | 0.30 | -0.61 | -0.14 | -0.90 | 1.07 |
| Operating Cash Flow Ratio | 1.03 | 0.97 | 0.72 | 0.34 | 0.98 |
| Short-Term Operating Cash Flow Coverage | 14.04 | 379.33 | 749.89 | 418.17 | 1369.05 |
| Net Current Asset Value | $ -216.70M | $ 235.50M | $ -509.60M | $ -728.44M | $ -2.12B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.15 | 0.11 | 0.10 | 0.01 |
| Debt-to-Equity Ratio | 0.21 | 0.21 | 0.16 | 0.14 | 0.02 |
| Debt-to-Capital Ratio | 0.17 | 0.17 | 0.14 | 0.13 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.15 | 0.15 | 0.12 | 0.11 | 0.00 |
| Financial Leverage Ratio | 1.42 | 1.43 | 1.41 | 1.40 | 1.30 |
| Debt Service Coverage Ratio | 11.21 | -32.81 | -8.85 | -89.48 | 2153.63 |
| Interest Coverage Ratio | 5.52 | 5.50 | 6.83 | 12.66 | 322.59 |
| Debt to Market Cap | 0.17 | 0.13 | 0.13 | 0.10 | 0.00 |
| Interest Debt Per Share | 57.95 | 50.46 | 49.81 | 47.88 | 7.54 |
| Net Debt to EBITDA | 0.83 | -0.41 | -1.53 | -0.21 | -0.04 |
| Profitability Margins | |||||
| Gross Profit Margin | 52.01% | 53.73% | 53.42% | 55.93% | 56.05% |
| EBIT Margin | 40.43% | -89.37% | -29.97% | -166.51% | 186.50% |
| EBITDA Margin | 46.84% | -83.46% | -24.51% | -161.62% | 191.21% |
| Operating Profit Margin | 10.47% | 10.48% | 12.65% | 17.22% | 17.12% |
| Pretax Profit Margin | 38.54% | -91.27% | -31.82% | -167.87% | 186.45% |
| Net Profit Margin | 29.42% | -71.86% | -23.86% | -129.45% | 145.57% |
| Continuous Operations Profit Margin | 29.42% | -71.86% | -23.86% | -129.45% | 145.57% |
| Net Income Per EBT | 76.33% | 78.73% | 74.97% | 77.11% | 78.07% |
| EBT Per EBIT | 368.02% | -870.82% | -251.66% | -974.74% | 1089.08% |
| Return on Assets (ROA) | 7.18% | -19.69% | -5.18% | -26.87% | 23.90% |
| Return on Equity (ROE) | 10.20% | -28.07% | -7.29% | -37.73% | 31.09% |
| Return on Capital Employed (ROCE) | 2.69% | 3.02% | 2.87% | 3.73% | 2.92% |
| Return on Invested Capital (ROIC) | 2.04% | 2.37% | 2.14% | 2.87% | 2.28% |
| Return on Tangible Assets | 7.74% | -21.30% | -5.51% | -28.42% | 24.74% |
| Earnings Yield | 9.20% | -19.90% | -6.76% | -28.96% | 18.87% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.47 | 5.67 | 5.46 | 5.67 | 6.90 |
| Payables Turnover | 9.61 | 9.71 | 8.61 | 9.14 | 9.05 |
| Inventory Turnover | 1.67 | 1.56 | 1.59 | 1.72 | 2.24 |
| Fixed Asset Turnover | 3.64 | 3.73 | 3.69 | 4.12 | 4.08 |
| Asset Turnover | 0.24 | 0.27 | 0.22 | 0.21 | 0.16 |
| Working Capital Turnover Ratio | 1.04 | 1.01 | 1.04 | 1.44 | 2.07 |
| Cash Conversion Cycle | 246.88 | 260.35 | 253.35 | 237.12 | 175.17 |
| Days of Sales Outstanding | 66.76 | 64.35 | 66.82 | 64.43 | 52.90 |
| Days of Inventory Outstanding | 218.10 | 233.58 | 228.95 | 212.61 | 162.61 |
| Days of Payables Outstanding | 37.98 | 37.59 | 42.42 | 39.91 | 40.34 |
| Operating Cycle | 284.86 | 297.93 | 295.76 | 277.03 | 215.51 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 19.52 | 16.13 | 12.84 | 6.53 | 22.44 |
| Free Cash Flow Per Share | 13.74 | 9.44 | 7.47 | 2.70 | 17.96 |
| Dividend Paid and CapEx Coverage Ratio | 3.38 | 2.41 | 2.39 | 1.70 | 5.01 |
| Capital Expenditure Coverage Ratio | 3.38 | 2.41 | 2.39 | 1.70 | 5.01 |
| Operating Cash Flow Coverage Ratio | 0.35 | 0.33 | 0.27 | 0.14 | 3.00 |
| Operating Cash Flow to Sales Ratio | 0.21 | 0.18 | 0.14 | 0.07 | 0.23 |
| Free Cash Flow Yield | 4.53% | 2.87% | 2.31% | 0.64% | 2.38% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.87 | -5.03 | -14.80 | -3.45 | 5.30 |
| Price-to-Sales (P/S) Ratio | 3.20 | 3.61 | 3.53 | 4.47 | 7.71 |
| Price-to-Book (P/B) Ratio | 1.11 | 1.41 | 1.08 | 1.30 | 1.65 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 22.05 | 34.82 | 43.21 | 155.99 | 42.07 |
| Price-to-Operating Cash Flow Ratio | 15.52 | 20.36 | 25.15 | 64.41 | 33.67 |
| Price-to-Earnings Growth (PEG) Ratio | -0.08 | -0.03 | 0.18 | 0.02 | 0.46 |
| Enterprise Value Multiple | 7.65 | -4.74 | -15.93 | -2.98 | 3.99 |
| Enterprise Value | 9.26B | 10.16B | 10.43B | 13.48B | 22.29B |
| EV to EBITDA | 7.65 | -4.74 | -15.93 | -2.98 | 3.99 |
| EV to Sales | 3.58 | 3.96 | 3.91 | 4.81 | 7.63 |
| EV to Free Cash Flow | 24.72 | 38.15 | 47.80 | 167.87 | 41.61 |
| EV to Operating Cash Flow | 17.40 | 22.31 | 27.83 | 69.32 | 33.30 |
| Tangible Book Value Per Share | 245.74 | 207.88 | 274.13 | 298.02 | 438.61 |
| Shareholders’ Equity Per Share | 273.40 | 232.84 | 299.26 | 322.82 | 458.76 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.24 | 0.21 | 0.25 | 0.23 | 0.22 |
| Revenue Per Share | 94.75 | 90.97 | 91.45 | 94.08 | 97.97 |
| Net Income Per Share | 27.87 | -65.36 | -21.82 | -121.79 | 142.61 |
| Tax Burden | 0.76 | 0.79 | 0.75 | 0.77 | 0.78 |
| Interest Burden | 0.95 | 1.02 | 1.06 | 1.01 | 1.00 |
| Research & Development to Revenue | 0.10 | 0.12 | 0.09 | 0.09 | 0.09 |
| SG&A to Revenue | 0.32 | 0.32 | 0.32 | 0.30 | 0.30 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Income Quality | 0.70 | -0.25 | -0.59 | -0.05 | 0.16 |
Currency in USD
